HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Update on long-term results with auditory brainstem implants in NF2 patients.

Abstract
This study reviews the long-term results of auditory brainstem implant (ABI) in neurofibromatosis type 2 (NF2) patients. Retrospective chart reviews of patients who received an ABI at the Melbourne Cochlear Implant Clinic since 1995. Ten patients with an average follow-up of five years were included. Three patients received the N22 ABI and seven received the N24. Two patients discontinued use of their devices. Users reported part-time use for approximately four to five hours per day, switching their implants off in noisy environments. Audiological analyses at one to seven years post-implantation indicate that N24 patients showed worse performance at one year post-implantation but they continued to improve and, in the long term, both N22 and N24 groups achieved similar results. In conclusion, ABI provides a safe and useful tool for aural rehabilitation in NF2 patients. This study confirms that gradual improvement in performance occurs beyond one year post-implantation, as speech perception scores continued to improve.
AuthorsSangeeta Maini, Mauricio A Cohen, Rod Hollow, Robert Briggs
JournalCochlear implants international (Cochlear Implants Int) Vol. 10 Suppl 1 Pg. 33-7 ( 2009) ISSN: 1754-7628 [Electronic] England
PMID19230037 (Publication Type: Journal Article)
CopyrightCopyright 2009 John Wiley & Sons, Ltd.
Topics
  • Adult
  • Auditory Brain Stem Implantation (instrumentation)
  • Follow-Up Studies
  • Humans
  • Middle Aged
  • Neurofibromatosis 2 (rehabilitation)
  • Neuroma, Acoustic (surgery)
  • Speech Perception
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: